West Pharmaceutical Services WST Stock
West Pharmaceutical Services Price Chart
West Pharmaceutical Services WST Financial and Trading Overview
| West Pharmaceutical Services stock price | 282.07 USD |
| Previous Close | 354.69 USD |
| Open | 352.95 USD |
| Bid | 143.92 USD x 800 |
| Ask | 575.66 USD x 800 |
| Day's Range | 351.93 - 361.3 USD |
| 52 Week Range | 206.19 - 376.72 USD |
| Volume | 417.41K USD |
| Avg. Volume | 419.24K USD |
| Market Cap | 26.71B USD |
| Beta (5Y Monthly) | 1.093309 |
| PE Ratio (TTM) | 49.220245 |
| EPS (TTM) | 6.74 USD |
| Forward Dividend & Yield | 0.76 (0.20%) |
| Ex-Dividend Date | July 25, 2023 |
| 1y Target Est | 369.22 USD |
WST Valuation Measures
| Enterprise Value | 25.76B USD |
| Trailing P/E | 49.220245 |
| Forward P/E | 41.308838 |
| PEG Ratio (5 yr expected) | 1.71 |
| Price/Sales (ttm) | 9.26391 |
| Price/Book (mrq) | 9.616464 |
| Enterprise Value/Revenue | 8.934 |
| Enterprise Value/EBITDA | 29.789 |
Trading Information
West Pharmaceutical Services Stock Price History
| Beta (5Y Monthly) | 1.093309 |
| 52-Week Change | 27.21% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 376.72 USD |
| 52 Week Low | 206.19 USD |
| 50-Day Moving Average | 355.15 USD |
| 200-Day Moving Average | 289.38 USD |
WST Share Statistics
| Avg. Volume (3 month) | 419.24K USD |
| Avg. Daily Volume (10-Days) | 342.78K USD |
| Shares Outstanding | 74.24M |
| Float | 73.84M |
| Short Ratio | 2.1 |
| % Held by Insiders | 0.52% |
| % Held by Institutions | 95.05% |
| Shares Short | 858.26K |
| Short % of Float | 1.50% |
| Short % of Shares Outstanding | 1.15% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.74 |
| Trailing Annual Dividend Yield | 0.20% |
| 5 Year Average Dividend Yield | 32.00% |
| Payout Ratio | 0.1015 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 19.14% |
| Operating Margin (ttm) | 25.74% |
| Gross Margin | 38.94% |
| EBITDA Margin | 29.99% |
Management Effectiveness
| Return on Assets (ttm) | 13.21% |
| Return on Equity (ttm) | 21.64% |
Income Statement
| Revenue (ttm) | 2.88B USD |
| Revenue Per Share (ttm) | 38.74 USD |
| Quarterly Revenue Growth (yoy) | -0.50% |
| Gross Profit (ttm) | 1.14B USD |
| EBITDA | 864.8M USD |
| Net Income Avi to Common (ttm) | 552.1M USD |
| Diluted EPS (ttm) | 7.31 |
| Quarterly Earnings Growth (yoy) | -19.40% |
Balance Sheet
| Total Cash (mrq) | 886.3M USD |
| Total Cash Per Share (mrq) | 11.94 USD |
| Total Debt (mrq) | 314.4M USD |
| Total Debt/Equity (mrq) | 11.33 USD |
| Current Ratio (mrq) | 3.622 |
| Book Value Per Share (mrq) | 37.415 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 710.9M USD |
| Levered Free Cash Flow (ttm) | 264.94M USD |
Profile of West Pharmaceutical Services
| Country | United States |
| State | PA |
| City | Exton |
| Address | 530 Herman O. West Drive |
| ZIP | 19341-0645 |
| Phone | 610 594 2900 |
| Website | https://www.westpharma.com |
| Industry | Medical Instruments & Supplies |
| Sector(s) | Healthcare |
| Full Time Employees | 10700 |
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. The company was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
Q&A For West Pharmaceutical Services Stock
What is a current WST stock price?
West Pharmaceutical Services WST stock price today per share is 282.07 USD.
How to purchase West Pharmaceutical Services stock?
You can buy WST shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for West Pharmaceutical Services?
The stock symbol or ticker of West Pharmaceutical Services is WST.
Which industry does the West Pharmaceutical Services company belong to?
The West Pharmaceutical Services industry is Medical Instruments & Supplies.
How many shares does West Pharmaceutical Services have in circulation?
The max supply of West Pharmaceutical Services shares is 71.94M.
What is West Pharmaceutical Services Price to Earnings Ratio (PE Ratio)?
West Pharmaceutical Services PE Ratio is 41.85015000 now.
What was West Pharmaceutical Services earnings per share over the trailing 12 months (TTM)?
West Pharmaceutical Services EPS is 6.74 USD over the trailing 12 months.
Which sector does the West Pharmaceutical Services company belong to?
The West Pharmaceutical Services sector is Healthcare.
West Pharmaceutical Services WST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| S&P 500 INDEX SPX | 6840.2 USD — |
+0.26
|
3.79B USD — | 6814.26 USD — | 6879.17 USD — | — - | 3.79B USD — |
| S&P 500 (Yahoo.com) GSPC | 6840.2 USD — |
+0.26
|
3.78B USD — | 6814.26 USD — | 6879.17 USD — | — - | 3.78B USD — |
| NQ US Medical Supplies Large M NQUSB4537LMN | 3087.37 USD — |
<0.01
|
— — | 3057.02 USD — | 3124.33 USD — | — - | — — |
| US Tech US Low Volatility Divide LVDA | 1255.04 USD — |
-0.45
|
— — | 1250.32 USD — | 1258.59 USD — | — - | — — |
| US Tech US Broad Dividend Achiev DAATR | 7637.04 USD — |
-0.24
|
— — | 7606.08 USD — | 7660.96 USD — | — - | — — |
| US Tech US CapEx Achievers Index CAPEXA | 3309.93 USD — |
-0.2
|
— — | 3295.49 USD — | 3322.51 USD — | — - | — — |
| NYSE Composite Index NYA | 21459.58 USD — |
+0.04
|
— — | 21350.03 USD — | 21510.64 USD — | — - | — — |
| US Tech DM Ex Japan Large Mid Ca NQDMXJPLMAUD | 2100.38 AUD 1390.15 USD |
<0.01
|
— — | 2100.38 AUD 1390.15 USD | 2100.38 AUD 1390.15 USD | — - | — — |
| US Tech US Broad Dividend Achiev DAA | 4127.32 USD — |
-0.26
|
— — | 4110.59 USD — | 4140.25 USD — | — - | — — |
- {{ link.label }} {{link}}


